Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(817/week)
    • Manufacturing(417/week)
    • Energy(348/week)
    • Technology(776/week)
    • Other Manufacturing(285/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Phosphate binders

Jun 15, 2020
Ardelyx Announces Positive Second Data Analysis from Ongoing NORMALIZE Phase 4 Study Evaluating Tenapanor in CKD Patients on Dialysis
Mar 31, 2020
New Retrospective Two-Year Study Demonstrates Velphoro® Effectiveness
Dec 03, 2019
Ardelyx Announces Positive Topline Results from Pivotal Phase 3 PHREEDOM Study Evaluating Tenapanor in CKD Patients on Dialysis
Sep 03, 2019
Ardelyx Announces Positive Results from the Pivotal Phase 3 AMPLIFY Study Evaluating Tenapanor in Dialysis Patients Who Have Uncontrolled Hyperphosphatemia Despite Phosphate Binder Treatment
Jun 25, 2019
US Nephrologists Report Few Gains in the CKD-MBD Market for Akebia's Auryxia, Amgen's Parsabiv, and Opko's Rayaldee Despite Reports That They Would Like to Expand Use of All Three Products
Mar 07, 2019
Ardelyx Announces Peer-Reviewed Publication of Positive Phase 3 Results of Tenapanor for the Treatment of Hyperphosphatemia in the Journal of the American Society of Nephrology
Feb 07, 2019
Ardelyx Collaboration Partner, Kyowa Hakko Kirin, Announces Initiation of a Phase 2 Clinical Study of Tenapanor for Hyperphosphatemia Patients on Dialysis in Japan
Jan 28, 2019
Velphoro® Doubles Percentage of Patients Reaching Target Serum Phosphorous Levels in New Study Published in Journal of Renal Nutrition
Nov 07, 2018
Ardelyx Reports Third Quarter 2018 Financial Results and Recent Highlights
Oct 26, 2018
Ardelyx Presents New Preclinical Data Demonstrating Synergy between Tenapanor and Sevelamer When Dosed in Combination for Elevated Serum Phosphorus
Mar 19, 2018
Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada
Nov 14, 2017
In the CKD-MBD Market, OPKO's Rayaldee Continues to Struggle While Keryx's Auryxia Gains Momentum, According to Latest Quarterly Update from Spherix Global Insights
Aug 10, 2017
Changes Afoot in the Management of CKD Mineral Bone Disorder Reinforced by a Clinical Practice Guideline Update from KDIGO

Latest News

Jul 7, 2025

Mitsubishi Electric’s ME Innovation Fund Invests in AI-assisted PLM Systems Startup “Things”

Jul 7, 2025

Faraday Future Founder and Co-CEO, YT Jia, Shares Weekly Investor Update

Jul 7, 2025

Valaris Announces Multi-Year Contract Awards for Drillships VALARIS DS-16 and DS-18

Jul 7, 2025

Groq Launches European Data Center Footprint in Helsinki, Finland

Jul 7, 2025

Nuevocor Strengthens Board with Appointment of Thierry Abribat

Jul 6, 2025

USAA Stands with Our Communities to Provide Support Amid Devastating Texas Floods

Jul 6, 2025

Sky Elements Sets Three New Guinness World Records

Jul 6, 2025

TECNO Unveils SPARK 40 Series: Ultra-Slim, Ultra-Strong Built for the Long Run

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia